Black Rock Inc. Clearside Biomedical, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CLSD
# of Institutions
48Shares Held
11.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.36MShares$14.1 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$9.21 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$6.32 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA790KShares$3.31 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0534KShares$2.24 Million0.03% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $252M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...